Tax Inversion Lobbying Booms as Corporations Fight Obama
This article is for subscribers only.
The number of companies lobbying the U.S. government on tax inversions more than doubled in the quarter ended Sept. 30, as they sought to prevent Congress and the Obama administration from imposing new restrictions.
Novartis AG, SAP SE, and Eaton Corp Plc were among companies that began lobbying on inversions and related issues after July 1. They could be affected by limits preventing them from loading U.S. subsidiaries with deductible debt. Companies with pending inversion deals, including Medtronic Inc. and Mylan Inc., also lobbied on the issue.